Alan Schatzberg

Alan F. Schatzberg is an American psychiatrist. He was the 136th president of the American Psychiatric Association (2009–2010).[1] Since 1991, he has been the Kenneth T. Norris Jr . Professor of Psychiatry and Behavioral Sciences at Stanford University School of Medicine, and he was chair of the department from 1991 to 2010.[2] He has received multiple national and international awards for his work as an investigator in the biology and treatment of depression.[2] He is also the co-editor-in-chief of the Journal of Psychiatric Research, along with Florian Holsboer.[3] He received an honorary doctorate from the Medical University of Vienna in 2011.[4]

Controversy

Alan Schatzberg, as the APA president in 2009–10, was identified as the principal investigator on a federal study into the drug mifepristone for use as an antidepressant being developed by Corcept Therapeutics, a company Schatzberg had created and in which he had several million dollars' equity.[5]

References

1. "PsychiatryOnline |". ajp.psychiatryonline.org. Archived from the original on 2012-09-28.
2. "Alan Schatzberg - Faculty & Researcher Profiles - Stanford School of Medicine". med.stanford.edu. Archived from the original on 2005-04-14.
3. Journal of Psychiatric Research Editorial Board. Elsevier. Retrieved 2017-11-11.
4. "Alan F. Schatzberg ist Ehrendoktor der MedUni Wien". Retrieved 2023-01-05.
5. Viñas, Maria José (January 8, 2008). "Stanford Researcher, Accused of Conflicts, Steps Down as NIH Principal Investigator". The Chronicle of Higher Education.

External links

• Psychiatrists Propose Revisions to Diagnosis Manual. Archived 2014-01-22 at the Wayback Machine via PBS Newshour, Feb 10, 2010 (interviews Schatzberg and Allen Frances on some of the main changes proposed in the DSM-5 draft)